Dermatopathology Laboratory of Central States (DLCS) is pleased to announce the appointment of Robert E. Nevin as President and CEO of DLCS, effective October 1st, 2012.
Online PR News – 01-October-2012 – Dayton, OH – Dermatopathology Laboratory of Central States (DLCS) is pleased to announce the appointment of Robert E. Nevin as President and CEO of DLCS, effective October 1st, 2012. Nevin, an executive with more than 20 years of experience in medical and pharmaceutical management, will assume overall leadership and strategic vision and strategy for the organization.
Nevin comes to DLCS, from Medicis Pharmaceutical Corporation in Scottsdale, AZ. Serving as Executive Director of Dermatology Sales, Nevin led the medical sales team for the leading independent specialty pharmaceutical company in the United States.
“Our physicians and staff are excited to work with Robert to grow our national laboratory while maintaining our independent spirit,” says Dr. Tom Olsen. “We are fortunate to have someone of his caliber and proven track record leading the team as we take our organization to the next level.”
Nevin earned his B.A. in Finance, Business Administration from Seton Hall University in South Orange, NJ.
“I am honored to be a part of such an exceptional company” commented Nevin, “I look forward to playing a part in DLCS’ success by providing world-class dermatopathology and striving to exceed the expectations of both physicians and patients.”
Dermpath Lab of Central States (DLCS) is an independent, national dermatopathology laboratory whose goal is to provide physicians with accurate diagnoses of skin biopsies. DLCS has a focus on quality, efficient service, and education – all essential to our dedication to patient care. For additional information about DLCS visit www.dermpathlab.com.